Article Text

Download PDFPDF
Imiquimod 5% cream reduced lesion size in vulvar intraepithelial neoplasia

Statistics from Altmetric.com

T Helmerhorst

Dr T Helmerhorst, Erasmus University Medical Center, Rotterdam, The Netherlands; t.helmerhorst@erasmusmc.nl

STUDY DESIGN

Design:

randomised placebo controlled trial.

Allocation:

concealed.*

Blinding:

blinded (patients, clinicians, outcome assessors, {data collectors, and safety committee}†).*

STUDY QUESTION

Setting:

2 academic medical centres in the Netherlands.

Patients:

52 women ⩾18 years of age (range 22–71 y) who had multifocal grade 2 or 3 vulvar intraepithelial neoplasia without microinvasion and used contraceptives if they were premenopausal and sexually active. Exclusion criteria included cancer or inflammatory dermatosis of the vulva, pregnancy, immunodeficiency, any treatment for vulvar intraepithelial neoplasia or warts within the previous month, and hypersensitivity to the study …

View Full Text

Footnotes

  • Source of funding: Erasmus University Medical Center; Rotterdam; Academic Medical Center, Amsterdam; 3M Pharmaceuticals provided the medication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.